Table 1.

Characteristics of patients depending on the presence or absence of MetS.

Characteristics	Patients with MetS (n = 43)	Patients without MetS (n = 71)	p-value
Age, Me [Q1; Q3] years	39 [30; 52]	32 [27; 37]	0.0005*
Sex [male, n (%)/female, n (%)]	27 (62.8)/16 (37.2)	32 (45.1)/39 (54.9)	0.067
Schizophrenia onset age, Me [Q1; Q3]	23 [19; 29]	22 [19; 26]	0.3162
Duration of disease, Me [Q1; Q3] years	16 [10; 22]	9 [4; 15]	0.0003*
Chlorpromazine equivalent doses, Me [Q1; Q3]	300 [212.5; 600]	400 [200; 600]	0.4657
PANSS, Me [Q1; Q3] total score	100 [87; 108]	94 [81; 106]	0.1299

*p < 0.05—statistically significant difference. Comparisons between groups were performed using chi-squared test for sex and Mann-Whitney U-test for the rest of the variables.